The Long Run with Luke Timmerman cover image

Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery

The Long Run with Luke Timmerman

CHAPTER

Is Small Molecule a Better Modality Than a Biologic?

Ess: Small molecule has certain advantages, like the lower cost of goods. One of the biggest is patient compliance. Biologics have revolutionized health care. They validate the target thit's a great opportunity.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner